Literature DB >> 1759182

Diagnosis and management of gliomatosis cerebri: recent trends.

I B Ross1, Y Robitaille, J G Villemure, D Tampieri.   

Abstract

Gliomatosis cerebri (GC) describes a diffuse overgrowth of the neuraxis by neoplastic glial cells with relative preservation of the underlying cytoarchitecture. Ten cases of GC are presented, followed by discussions of its radiological and pathological characteristics. The diagnosis of GC was formerly made only at autopsy. However, recent improvements in imaging and biopsy now allow for antemortem diagnosis. Immunocytochemistry for S-100 protein and glial fibrillary acidic protein (GFAP) in three open biopsies of early primary GC revealed diffuse proliferation of S-100 immunoreactive and GFAP-resistant small astrocytes. Magnetic resonance imaging appears to be the imaging modality of choice. T2-weighted images generally show contiguous high intensity signal in affected areas. Biopsy, either open or stereotactic, remains necessary for antemortem diagnosis. No treatment has proven effective for GC, the prognosis being poor. The authors also review theories of tumorigenesis of GC in an effort to explain its biology.

Entities:  

Mesh:

Year:  1991        PMID: 1759182     DOI: 10.1016/0090-3019(91)90156-4

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  19 in total

1.  Gliomatosis cerebri: post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide.

Authors:  C Mawrin; V Aumann; E Kirches; R Schneider-Stock; C Scherlach; S Vogel; U Mittler; K Dietzmann; G Krause; S Weis
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

2.  Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature.

Authors:  Sophie Taillibert; Catherine Chodkiewicz; Florence Laigle-Donadey; Massimo Napolitano; Stéphanie Cartalat-Carel; Marc Sanson
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

3.  Exclusive radiotherapy for gliomatosis cerebri: long-term follow-up at a single institution.

Authors:  K Kim; E K Chie; H J Park; D G Kim; H-W Jung; S-H Park; I H Kim
Journal:  Clin Transl Oncol       Date:  2014-01-29       Impact factor: 3.405

4.  Gliomatosis cerebri and pituitary adenoma: case report and literature review.

Authors:  A Mangiola; P De Bonis; M Guerriero; A Pompucci; C Anile
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

5.  Corticosteroid sensitivity in gliomatosis cerebri delays diagnosis.

Authors:  Jan Bittar; Carlos Kamiya-Matsuoka; Pedro C Barata; Soo-Hyun Lee-Kim; Adriana Olar; Ivo W Tremont-Lukats
Journal:  Pract Neurol       Date:  2015-04-28

6.  Gliomatosis cerebri: a review.

Authors:  Roberta Rudà; Luca Bertero; Marc Sanson
Journal:  Curr Treat Options Neurol       Date:  2014-02       Impact factor: 3.598

7.  Gliomatosis cerebri or benign intracranial hypertension?

Authors:  P Weston; J Lear
Journal:  Postgrad Med J       Date:  1995-06       Impact factor: 2.401

8.  Presentation patterns and outcome of gliomatosis cerebri.

Authors:  Gustavo G Rajz; Dvora Nass; Elisa Talianski; Raphael Pfeffer; Roberto Spiegelmann; Zvi R Cohen
Journal:  Oncol Lett       Date:  2011-10-18       Impact factor: 2.967

9.  A difficult diagnosis of gliomatosis cerebri.

Authors:  J Pyhtinen; E Pääkkö
Journal:  Neuroradiology       Date:  1996-07       Impact factor: 2.804

10.  Gliomatosis cerebri: clinical characteristics, management, and outcomes.

Authors:  Selby Chen; Shota Tanaka; Caterina Giannini; Jonathan Morris; Elizabeth S Yan; Jan Buckner; Daniel H Lachance; Ian F Parney
Journal:  J Neurooncol       Date:  2013-01-23       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.